{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:17:57Z","timestamp":1760782677644},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[1992,1,1]],"date-time":"1992-01-01T00:00:00Z","timestamp":694224000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[1992]]},"DOI":"10.1007\/bf00638238","type":"journal-article","created":{"date-parts":[[2004,11,26]],"date-time":"2004-11-26T14:31:26Z","timestamp":1101479486000},"page":"S30-S36","source":"Crossref","is-referenced-by-count":31,"title":["Vitamin D3 and skin diseases"],"prefix":"10.1007","volume":"284","author":[{"given":"K.","family":"Kragballe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.1073\/pnas.82.16.5409","volume":"82","author":"J Abe","year":"1985","unstructured":"Abe J, Kondo S, Nishii Y, Kuroki T (1985) Resistance to 1,25-dihydroxyvitamin D3 of cultured psoriatic epidermal keratinocytes isolated from involved and uninvolved skin. Proc Natl Acad Sci USA 82: 5409?5412","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR2","unstructured":"Ashenfelter A, Coutinho J, Gwo J, Zultak M, Armstrong R (1992) Calcitriol cream in the treatment of psoriasis: efficacy and safety considerations (abstract). In: Roenigk HH Jr, Maibach HI (eds) Proceedings of the 4th International Psoriasis Symposium. San Francisco, USA, July 10?14, p 108"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1515\/9783110850345-168","volume-title":"Vitamin D: gene regulation structure-function analysis and clinical application","author":"M Bagot","year":"1991","unstructured":"Bagot M, Charue D, Pamphile R, Revux J (1991) Immunosuppressive effects of 1,25-dihydroxyvitamin D3 analogue (calcipotriol) on epidermal cells. In: Norman AW, Bouillon R, Thomasset M (eds) Vitamin D: gene regulation structure-function analysis and clinical application. De Gruyter, Berlin, pp 518?519"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1073\/pnas.85.4.1223","volume":"85","author":"J Barsony","year":"1988","unstructured":"Barsony J, Marx SJ (1988) Receptor mediated rapid action of 1,25-dihydroxy cholecalciferol: increase of intracellular cyclic GMP in human skin fibrolasts. Proc Natl Acad Sci USA 85: 1223?1226","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1021\/bi00355a013","volume":"25","author":"DD Bikle","year":"1986","unstructured":"Bikle DD, Nemanic MK, Whitney JO, Elias P (1986) Neonatal human foreskin keratinocytes produce 1,25-dihydroxyvitamin D3. Biochemistry 25: 1545?1548","journal-title":"Biochemistry"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/0006-2952(88)90177-3","volume":"37","author":"L Binderup","year":"1988","unstructured":"Binderup L, Bramm E (1988) Effect of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo. Biochem Pharmacol 37: 889?895","journal-title":"Biochem Pharmacol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/0006-2952(91)90426-6","volume":"42","author":"L Binderup","year":"1991","unstructured":"Binderup L, Latini S, Binderup E, Breting C, Calverley M, Hansen K (1991) 20-Epi-vitamin D3 analogues: a novel class of potent regulators of cell growth and immune responses. Biochem Pharmacol 42: 1569?1575","journal-title":"Biochem Pharmacol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1365-2133.1991.tb00566.x","volume":"124","author":"B Bittiner","year":"1991","unstructured":"Bittiner B, Bleehen SS, McNeil S (1991) 1-alpha, 25(OH)2D3 increases intracellular calcium in human keratinocytes. Br J Dermatol 124: 230?235","journal-title":"Br J Dermatol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1210\/jcem-56-4-824","volume":"56","author":"TL Clemens","year":"1983","unstructured":"Clemens TL, Adams JS, Horiuchi N, Gilchrest BA, Cho H, Tsuchiya Y, Matsuo N, Suda T, Holick MF (1983) Interaction 1,25-dihydroxyvitamin D3 with keratinocytes and fibroblasts from skin of normal subjects and a subject with vitamin D dependent rickets type II: a model for study of the mode of action 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metabol 56: 824?830","journal-title":"J Clin Endocrinol Metabol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/0190-9622(92)70103-M","volume":"26","author":"WJ Cunliffe","year":"1992","unstructured":"Cunliffe WJ, Claudy A, Fairiss G, Goldin D, Gratton D, Holden CA, Berth-Jones J, Maddin WS, Ortonne J-P, Henderson CA, Young M (1992) A multicentre comparative study of calcipotriol and betamethasone 17-valerate in patients with psoriasis vulgaris. J Am Acad Dermatol 26: 736?743","journal-title":"J Am Acad Dermatol"},{"key":"CR11","doi-asserted-by":"crossref","unstructured":"Dubertret L, Wallach D, Souteyrand P, Perusell M, Maynadiet J, Chevtrant-Breton J, Beylot C, Basex JA, J\u00fcrgensen HJ (1992) Efficacy and safety of calcipotriol (MC903) ointment in psoriasis vulgaris. J Am Acad Dermatol (in press)","DOI":"10.1016\/0190-9622(92)70299-U"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/0140-6736(91)91493-E","volume":"338","author":"C Dwyer","year":"1991","unstructured":"Dwyer C, Chapman RS (1991) Calcipotriol and hypercalcemia. Lancet 338: 764?765","journal-title":"Lancet"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1073\/pnas.78.4.2562","volume":"78","author":"C Eil","year":"1981","unstructured":"Eil C, Marx SJ (1981) Nuclear uptake of 1,25-dihydroxy cholecalciferol in dispersed fibroblasts cultured from normal human skin. Proc Natl Acad Sci USA 78: 2562?2566","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1210\/jcem-51-6-1463","volume":"51","author":"D Feldman","year":"1980","unstructured":"Feldman D, Chen T, Hirst M, Colston K, Karasek M, Cone C (1980) Demonstration of 1,25-dihydroxyvitamin D3 receptor in human skin biopsies. J Clin Endocrinol Metab 51: 1463?1465","journal-title":"J Clin Endocrinol Metab"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2340\/0001555570351354","volume":"70","author":"JJ Guilhou","year":"1990","unstructured":"Guilhou JJ, Colette C, Monpoint S, Lancrenon E, Guillot B, Monnier L (1990) Vitamin D metabolism in psoriasis before and after phototherapy. Acta Derm Venereol (Stockh) 70: 351?354","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1146\/annurev.nu.06.070186.002523","volume":"6","author":"MR Haussler","year":"1986","unstructured":"Haussler MR (1986) Vitamin D receptors: nature and function. Annu Rev Nutr 6: 527?562","journal-title":"Annu Rev Nutr"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2133.1989.tb15517.x","volume":"121","author":"CA Henderson","year":"1989","unstructured":"Henderson CA, Papworth-Smith J, Cunliffe WJ, Highet AS, Shamy HK, Czarnetzki BM (1989) A double-blind placebo-controlled trial of topical 1,25-dihydroxycalciferol in psoriasis. Br J Dermatol 121: 493?496","journal-title":"Br J Dermatol"},{"key":"CR18","first-page":"446","volume":"92","author":"MF Holick","year":"1989","unstructured":"Holick MF, Pochi P, Bhawan J (1989) Topically applied and orally administered 1,25-dihydroxyvitamin D3 is a novel, safe, effective therapy for the treatment of psoriasis: a three year experience and histologic analysis. J Invest Dermatol 92: 446","journal-title":"J Invest Dermatol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000210803","volume":"2","author":"DB Holland","year":"1989","unstructured":"Holland DB, Wood EJ, Roberts SG, West MR, Cunliffe WJ (1989) Epidermal cytokeratin levels during oral 1-alphahydroxyvitamin D3 treatment for psoriasis. Skin Pharmacol 2: 68?76","journal-title":"Skin Pharmacol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1210\/endo-113-6-1950","volume":"113","author":"J Hosomi","year":"1983","unstructured":"Hosomi J, Hosoi J, Abe E, Suda Kuroki T (1983) Regulation of terminal differentiation of mouse cultured epidermal cells by 1,25-dihydroxyvitamin D3. Endocrinology 113: 1950?1957","journal-title":"Endocrinology"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1365-2133.1986.tb06237.x","volume":"115","author":"T Kato","year":"1986","unstructured":"Kato T, Rokugo M, Terui T, Tagami H (1986) Successful treatment of psoriasis with topical application of the active vitamin D3 analogue, 1,24-dihydroxycholecalciferol. Br J Dermatol 115: 431?433","journal-title":"Br J Dermatol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/0006-2952(91)90160-7","volume":"41","author":"A-M Kissmeyer","year":"1991","unstructured":"Kissmeyer A-M, Binderup L (1991) Calcipotriol (MC 903): pharmaco-kinetics in rats and biological activities of metabolites. A comparative study with 1,25(OH)2D3. Biochem Pharmacol 41: 1601?1606","journal-title":"Biochem Pharmacol"},{"key":"CR23","first-page":"2734","volume":"48","author":"M Koga","year":"1988","unstructured":"Koga M, Eisman JA, Sutherland RL (1988) Regulation of epidermal growth factor receptor levels by 1,25-dihydroxyvitamin D3 in human breast cancer cells. Cancer Res 48: 2734?2739","journal-title":"Cancer Res"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1001\/archderm.1989.01670240047011","volume":"125","author":"K Kragballe","year":"1989","unstructured":"Kragballe K (1989) Treatment of psoriasis by the topical application of the novel cholecaliferol analogue calcipotriol (MC 903). Arch Dermatol 125: 1647?1652","journal-title":"Arch Dermatol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2340\/0001555571475478","volume":"71","author":"K Kragballe","year":"1991","unstructured":"Kragballe K, Fogh K (1991) Long-term efficacy and tolerability of topical calcipotriol in psoriasis. Acta Dermatol Venereol (Stockh) 71: 475?478","journal-title":"Acta Dermatol Venereol (Stockh)"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/BF00372616","volume":"282","author":"K Kragballe","year":"1990","unstructured":"Kragballe K, Wildfang I-L (1990) Calcipotriol (CM 903), a novel vitamin D3 analogue stimulates terminal differentiation and inhibits proliferation of cultured human keratinocytes. Arch Dermatol Res 282: 164?167","journal-title":"Arch Dermatol Res"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2133.1988.tb03204.x","volume":"199","author":"K Kragballe","year":"1988","unstructured":"Kragballe K, Beck H-I, S\u00d8gaard H (1988) Improvement of psoriasis by a topical vitamin D3 analogue (MC 903) in a double-blind study. Br J Dermatol 199: 223?230","journal-title":"Br J Dermatol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0140-6736(91)92157-W","volume":"337","author":"K Kragballe","year":"1991","unstructured":"Kragballe K, Gjertsen BT, De Hoope D, Karlsmark T, Kerkhof P van de, Lark\u00f6 P, Niesboer C, Roed-Petersen J, Strand A, Tikj\u00f6b G (1991) Double-blind, right-left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet 337: 193?196","journal-title":"Lancet"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1515\/9783110850345-134","volume-title":"Vitamin D: gene regulation structure-function analysis and clinical application","author":"A Langner","year":"1991","unstructured":"Langner A, Verjans H, Stapor V, Mol M, Elzerman J (1991) Treatment of chronic plaque psoriasis by 1-alpha,25-dihydroxyvitamin D3 ointment. In: Norman AW, Buillon R, Thomasset M (eds) Vitamin D: gene regulation structure-function analysis and clinical application. de Gruyter, Berlin, pp 430?431"},{"key":"CR30","doi-asserted-by":"crossref","unstructured":"Larsen CG, Kristensen M, Paludan K, Deleuran B, Thomsen MK, Zachariae C, Kragballe K, Matsushima K, Thestrup-Pedersen K 1,25(OH)2D3 regulator of interleukin-8 expression and production. Biochem Biophys Res Commun 176: 1020?1026","DOI":"10.1016\/0006-291X(91)90384-J"},{"key":"CR31","first-page":"450","volume":"82","author":"A Lugo-Somolinos","year":"1990","unstructured":"Lugo-Somolinos A, Sanxhez JL, Haddock L (1990) Efficacy of 1,25-dihydroxyvitamin D3 (calcitriol) in the treatment of psoriasis vulgaris: an open study. Bol Asoc Med PR 82: 450?453","journal-title":"Bol Asoc Med PR"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/8756-3282(90)90211-G","volume":"11","author":"PJ Marie","year":"1990","unstructured":"Marie PJ, Connes D, Hott M, Miravet L (1990) Comparative effects of a novel vitamin D analogue MC 903 and 1,25-dihydroxyvitamin D3 on alkaline phosphatase activity osteocalcin and DNA synthesis by human osteoblastic cells in culture. Bone 11: 171?179","journal-title":"Bone"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/0006-291X(90)90898-W","volume":"166","author":"K Matsumoto","year":"1990","unstructured":"Matsumoto K, Hashimoto K, Nishida Y, Hashiro M, Yoshikawa K (1990) Growth inhibitory effects of 1,25-dihydroxyvitamin D3 on normal human keratinocytes cultured in serum-free medium. Biochem Biophys Res Commun 166: 916?923","journal-title":"Biochem Biophys Res Commun"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1346-8138.1990.tb03714.x","volume":"17","author":"K Matsumoto","year":"1990","unstructured":"Matsumoto K, Hashimoto K, Kiyoki M, Yamamoto, Yoshikawa K (1990) Effect of 1,24R-dihydroxyvitamin D3 on the growth of human keratinocytes. J Dermatol 17: 97?103","journal-title":"J Dermatol"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1346-8138.1990.tb01614.x","volume":"17","author":"T Matsunaga","year":"1990","unstructured":"Matsunaga T, Yamamoto M, Mimura H, Ohta T, Kiyoki M, Ohba T, Naruchi T, Hosoi J, Kuroki T (1990) 1,24R-dihydroxyvitamin D3, a novel active form of vitamin D3 with high activity for inducing epidermal differentiation but decreased hypercalcemic activity. J Dermatol 17: 135?142","journal-title":"J Dermatol"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1515\/9783110850345-132","volume-title":"Vitamin D: gene regulation structure-function analysis and clinical application","author":"JA McLane","year":"1991","unstructured":"McLane JA, Kim H-J, Abdelkader N, Katz M (1991) 1,25(OH)2D3 enhances antiproliferative effect and transcription of TGF-beta 1 on human keratinocytes. In: Norman AW, Boullin R, Thomasset M (eds) Vitamin D: gene regulation structure-function analysis and clinical application. de Gruyter, Berlin pp. 426?427"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.1073\/pnas.82.16.5409","volume":"82","author":"JA McLaughlin","year":"1985","unstructured":"McLaughlin JA, Gange W, Taylor D, Smith EL, Holick MF (1985) Cultured psoriatic fibroblasts from involved and uninvolved sites have partial, but not absolute resistance to the proliferation-inhibition activity of 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 82: 5409?5412","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/1523-1747.ep12480255","volume":"97","author":"P Milde","year":"1991","unstructured":"Milde P, Hauser U, Simon T, Mall G, Ernst V, Haussler MR, Frosch P, Rauterberg EW (1991) Expression of 1,25-dihydroxyvitamin D3 receptors in normal and psoriatic skin. J Invest Dermatol 97: 230?236","journal-title":"J Invest Dermatol"},{"key":"CR39","first-page":"51","volume":"35","author":"S Morimoto","year":"1985","unstructured":"Morimoto S, Yoshikawa K (1985) A patient with psoriasis cured by 1-alpha-hydroxyvitamin D3. Med J Osaka Univ 35: 51?54","journal-title":"Med J Osaka Univ"},{"key":"CR40","first-page":"1020","volume":"176","author":"S Morimoto","year":"1986","unstructured":"Morimoto S, Yoshikawa K, Kozuka T, Kitano Y, Imanaka S, Fukuo K, Koh E, Kumahara Y (1986) An open study of vitamin D3 treatment in psoriasis vulgaris. Br J Dermatol 176: 1020?1026","journal-title":"Br J Dermatol"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0923-1811(90)90120-3","volume":"1","author":"S Morimoto","year":"1990","unstructured":"Morimoto S, Yoshikawa K, Fukuo K, Shiraishi T, Koh E, Imanaka S, Kitano S, Ogihara T (1990) Inverse relationship between serverity of psoriasis and serum 1,25-dihydroxyvitamin D level. J Dermatol Sci 1: 277?282","journal-title":"J Dermatol Sci"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1515\/9783110850345-141","volume-title":"Vitamin D: gene regulation structure-function analysis and clinical application","author":"L Mortensen","year":"1991","unstructured":"Mortensen L, Kragballe K, Schifter S, Charles P (1991) Effect of calcipotriol on psoriasis: a double-blind, placebo-controlled study of calcipotriol (MC 903) and calcium metabolism. In Norman AW, Buillon R, Thomasset M (eds) Vitamin D: gene regulation structure-function analysis and clinical application. Gruyter, Berlin, pp 443?444"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0165-2478(88)90012-0","volume":"17","author":"K M\u00fcller","year":"1988","unstructured":"M\u00fcller K, Svenson M, Bendtzen K (1988) 1-alpha,25-dihydroxyvitamin D3 and a novel vitamin D analogue MC 903 are potent inhibitors of human interleukin-1 in vitro. Immunol Lett 17: 361?366","journal-title":"Immunol Lett"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1073\/pnas.84.10.3385","volume":"84","author":"H Reichel","year":"1987","unstructured":"Reichel H, Koeffler HP, Tobler A, Norman AW (1987) 1,25-dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal peripheral blood lymphocytes. Proc Natl Acad Sci USA 84: 3385?3389","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1172\/JCI113004","volume":"70","author":"WFC Rigby","year":"1987","unstructured":"Rigby WFC, Denome S, Fanger MW (1987) Regulation of lymphokine productin and T lymphocyte activation by 1,25-dihydroxyvitamin D3: specific inhibition at level of messenger RNA. J Clin Invest 70: 1659?1664","journal-title":"J Clin Invest"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2133.1973.tb02980.x","volume":"89","author":"G Risum","year":"1973","unstructured":"Risum G (1973) Psoriasis exaberbated by hypoparathyrdism with hypocalcemia. Br J Dermatol 89: 309?312","journal-title":"Br J Dermatol"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/1523-1747.ep12276326","volume":"86","author":"EL Smith","year":"1986","unstructured":"Smith EL, Walworth NC, Holick MF (1986) Effect of 1,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes growth in serum-free conditions. J Invest Dermatol 86: 706?716","journal-title":"J Invest Dermatol"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0190-9622(88)80255-X","volume":"19","author":"EL Smith","year":"1988","unstructured":"Smith EL, Pincus SH, Donovan L, Holick MF (1988) A novel approach for the evaluation and treatment of psoriasis. J Am Acad Dermatol 19: 360?364","journal-title":"J Am Acad Dermatol"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2340\/00015555676568","volume":"67","author":"B Staberg","year":"1987","unstructured":"Staberg B, Oxholm A, Klemp P, Christansen C (1987) Abnormal vitamin D metabolism in patients with psoriasis. Acta Derm Venereol (Stockh) 67: 65?68","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"CR50","first-page":"147","volume":"69","author":"B Staberg","year":"1989","unstructured":"Staberg B, Roed-Pedersen J, Menne T (1989) Efficacy of topical treatment in psoriasis with MC 903, a new vitamin D analogue. Acta Derm Venereol (Stockh) 69: 147?150","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"677","DOI":"10.7326\/0003-4819-100-5-677","volume":"100","author":"AF Stewart","year":"1984","unstructured":"Stewart AF, Battaglini-Sabetta J, Millstone L (1984) Hypocalcemia-induced pustular psoriasis of von Zumbusch. Ann Intern Med 100: 677?680","journal-title":"Ann Intern Med"},{"key":"CR52","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1126\/science.505004","volume":"206","author":"WE Stumpf","year":"1979","unstructured":"Stumpf WE, Sar M, Reid FA, Tanaka Y, De Luca HG (1979) Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary and parathyroid. Science 206: 1188?1190","journal-title":"Science"},{"key":"CR53","first-page":"958","volume-title":"Proceedings of the Seventh Workshop on Vitamin D","author":"H Tagami","year":"1988","unstructured":"Tagami H, Kato T, Terui T, Tadaki T (1988) Successful treatment of psoriasis with topical application of the active vitamin D3 analog, 1 alpha, 24-dihydroxycholecaliferol. In: Norman WA, Schaeffer K, Grigoleit H-G, Herrath D (eds) Proceedings of the Seventh Workshop on Vitamin D. Gruyter, Berlin, pp 958?967"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/1523-1747.ep12515934","volume":"96","author":"W Tang","year":"1991","unstructured":"Tang W, Ziboh VA (1991) Agonist\/inositol triphosphate-induced release of calcium from murine keratinocytes: a possible link with keratinocytes differentiation. J Invest Dermatol 96: 134?138","journal-title":"J Invest Dermatol"},{"key":"CR55","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1365-2133.1989.tb01353.x","volume":"120","author":"PCM Kerkhof Van de","year":"1989","unstructured":"Van de Kerkhof PCM, Bokhoven M van, Zultak M, Czarnetzki MB (1989) A double-blind study of topical 1,25-dihydroxyvitamin D3 in psoriasis. Br J Dermatol 120: 661?664","journal-title":"Br J Dermatol"},{"key":"CR56","volume-title":"Vitamin D: gene regulation structure-function analysis and clinical application","author":"P Veyron","year":"1991","unstructured":"Veyron P, Pamphile R, Binderup L, Touraine JL (1991) Immunological properties of 1,25-dihydroxyvitamin D3 analogues: a strong effect on the prolongation of mouse skin allograft survival. In: Norman AW, Bouillon R, Thomasset M (eds) Vitamin D: gene regulation structure-function analysis and clinical application. Gruyter, Berlin"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00638238.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00638238\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00638238","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T22:19:54Z","timestamp":1705357194000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00638238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992]]},"references-count":56,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1992]]}},"alternative-id":["BF00638238"],"URL":"https:\/\/doi.org\/10.1007\/bf00638238","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992]]}}}